• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

p16+口咽癌去强化治疗方案的生活质量结局比较。

Comparison of quality of life outcomes in a de-intensification treatment regimen for p16 + oropharyngeal cancer.

机构信息

Division of Otolaryngology-Head and Neck Surgery, George Washington University School of Medicine and Health Sciences, 2300 M Street, NW, 4th Floor, Washington, DC, 20037, USA.

Division of Hematology and Oncology, George Washington University School of Medicine and Health Sciences, Washington, DC, USA.

出版信息

Eur Arch Otorhinolaryngol. 2022 Sep;279(9):4533-4540. doi: 10.1007/s00405-022-07387-7. Epub 2022 Apr 23.

DOI:10.1007/s00405-022-07387-7
PMID:35461409
Abstract

BACKGROUND

Platinum and taxane-based neoadjuvant chemotherapy with surgery (NAC + S) is a novel de-intensified treatment modality that is currently under investigation.

METHODS

All patients treated for HPV positive OPSCC with NAC + S at a single institution between 2006 and 2020 were contacted to complete the University of Washington Quality of life questionnaire (UW-QOL) at least 2 years following the completion of treatment.

RESULTS

The UW-QOL surveys were received from 25 of 48 eligible patients (52.1%). The mean follow-up time was 4.3 years (range 2.0-7.6 years). The overall mean score for the physical subscale was 92.4 (Standard deviation, SD = 10.9), and the social-emotional subscale was 91.1 (11.8). Compared to the normative cohort, the NAC + S cohort had a worse appearance (Mean scores Normative vs. NAC + S: 93 vs. 84.0, p = 0.009).

CONCLUSION

NAC + S offers favorable long-term QOL, as evidenced by near-normal scores in most QOL domains.

摘要

背景

含铂类和紫杉类药物的新辅助化疗联合手术(NAC+S)是一种新的去强化治疗方式,目前正在研究中。

方法

在 2006 年至 2020 年期间,在一家机构接受 NAC+S 治疗 HPV 阳性口咽鳞状细胞癌的所有患者都被联系,要求在完成治疗后至少 2 年完成华盛顿大学生活质量问卷(UW-QOL)。

结果

共收到 48 名符合条件的患者中的 25 名(52.1%)的 UW-QOL 调查。平均随访时间为 4.3 年(范围 2.0-7.6 年)。身体子量表的总体平均得分为 92.4(标准差,SD=10.9),社会情感子量表为 91.1(11.8)。与规范队列相比,NAC+S 队列的外观更差(规范队列与 NAC+S 队列的平均得分:93 与 84.0,p=0.009)。

结论

NAC+S 提供了有利的长期生活质量,大多数生活质量领域的得分接近正常。

相似文献

1
Comparison of quality of life outcomes in a de-intensification treatment regimen for p16 + oropharyngeal cancer.p16+口咽癌去强化治疗方案的生活质量结局比较。
Eur Arch Otorhinolaryngol. 2022 Sep;279(9):4533-4540. doi: 10.1007/s00405-022-07387-7. Epub 2022 Apr 23.
2
Swallowing Function Following Neoadjuvant Chemotherapy and Transoral Robotic Surgery for Oropharyngeal Carcinoma: A 2-Year Follow-up.新辅助化疗和经口机器人手术治疗口咽癌后的吞咽功能:2 年随访。
Otolaryngol Head Neck Surg. 2022 Aug;167(2):298-304. doi: 10.1177/01945998211057430. Epub 2021 Nov 9.
3
Prospective quality of life outcomes for human papillomavirus associated oropharynx cancer patients after surgery alone.单纯手术后 HPV 相关口咽癌患者的预期生活质量结局。
Am J Otolaryngol. 2023 Jul-Aug;44(4):103915. doi: 10.1016/j.amjoto.2023.103915. Epub 2023 May 5.
4
Treatment modality impact on quality of life for human papillomavirus-associated oropharynx cancer.治疗方式对人乳头瘤病毒相关性口咽癌患者生活质量的影响。
Laryngoscope. 2020 Feb;130(2):E48-E56. doi: 10.1002/lary.27937. Epub 2019 Mar 27.
5
Quality of life in head and neck cancer patients: impact of HPV and primary treatment modality.头颈部癌症患者的生活质量:人乳头瘤病毒和初始治疗方式的影响。
Laryngoscope. 2014 Jul;124(7):1592-7. doi: 10.1002/lary.24508. Epub 2013 Dec 18.
6
Patient-reported quality-of-life outcomes after de-escalated chemoradiation for human papillomavirus-positive oropharyngeal carcinoma: Findings from a phase 2 trial.人乳头瘤病毒阳性口咽癌降阶梯放化疗后患者报告的生活质量结局:来自 2 期试验的结果。
Cancer. 2018 Feb 1;124(3):521-529. doi: 10.1002/cncr.30954. Epub 2017 Oct 17.
7
Transoral robotic surgery for oropharyngeal cancer: long-term quality of life and functional outcomes.经口机器人手术治疗口咽癌:长期生活质量和功能预后。
JAMA Otolaryngol Head Neck Surg. 2013 Nov;139(11):1099-108. doi: 10.1001/jamaoto.2013.2747.
8
Long-term Quality of Life After Treatment of Oropharyngeal Squamous Cell Carcinoma.口咽鳞状细胞癌治疗后的长期生活质量。
Laryngoscope. 2021 Apr;131(4):E1172-E1178. doi: 10.1002/lary.29042. Epub 2020 Aug 25.
9
Long-term quality of life & functional outcomes after treatment of oropharyngeal cancer.口咽癌治疗后的长期生活质量和功能结局。
Cancer Med. 2021 Jan;10(2):483-495. doi: 10.1002/cam4.3599. Epub 2020 Dec 4.
10
Decisional regret, symptom burden, and quality of life following transoral robotic surgery for oropharyngeal cancer.口咽癌经口机器人手术后的决策性遗憾、症状负担和生活质量
Oral Oncol. 2023 Nov;146:106537. doi: 10.1016/j.oraloncology.2023.106537. Epub 2023 Aug 12.

引用本文的文献

1
Risk Stratification in HPV-Associated Oropharyngeal Cancer: Limitations of Current Approaches and the Search for Better Solutions.人乳头瘤病毒相关口咽癌的风险分层:当前方法的局限性及寻找更好的解决方案
Cancers (Basel). 2025 Jan 22;17(3):357. doi: 10.3390/cancers17030357.
2
Pathologic responses and clinical outcomes with neoadjuvant doublet chemotherapy for newly diagnosed, surgically-resectable p16-positive oropharyngeal cancer.新诊断的、可手术切除的p16阳性口咽癌采用新辅助双药化疗的病理反应和临床结果。
Oral Oncol. 2025 Feb;161:107139. doi: 10.1016/j.oraloncology.2024.107139. Epub 2025 Jan 8.
3
Patient-Reported Outcome Measures of Psychosocial Quality of Life in Oropharyngeal Cancer Patients: A Scoping Review.
口咽癌患者心理社会生活质量的患者报告结局指标:一项范围综述
J Clin Med. 2023 Mar 8;12(6):2122. doi: 10.3390/jcm12062122.